ConductScience.org, home

Paper691003

Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.

Petersen HJ and 2 others. J Med Chem, 1978. Cited by 119 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines. Papers, record 691003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/691003

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
PubMed
Journal
J Med Chem
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
4.54
iCite
Revised in PubMed
2019-07-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Petersen HJH J
2Nielsen CKC K
3Arrigoni-Martelli EE

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
GuanidinesMajor topic
Animals
Dogs
Female
Hypertension
Lethal Dose 50
Mice
Rats
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
34025808Synthetic accesses to biguanide compounds.Beilstein J Org Chem2021https://conductscience.org/library/papers/34025808PubMed
26935206Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity.Metallomics2016https://conductscience.org/library/papers/26935206PubMed
7783838Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism.Neurochem Res1995https://conductscience.org/library/papers/7783838PubMed
7647022Pharmacology of the potassium channel openers.Cardiovasc Drugs Ther1995https://conductscience.org/library/papers/7647022PubMed
7379920N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.Experientia1980https://conductscience.org/library/papers/7379920PubMed
6974455An unusual profile of activity of a new basic anti-inflammatory drug, timegadine.Agents Actions1981https://conductscience.org/library/papers/6974455PubMed
6653652Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653652PubMed
6468476Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6468476PubMed
4029244Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4029244PubMed
4029243Long-term effects of pinacidil in hypertensive dialysis patients.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4029243PubMed
4007040Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4007040PubMed
3978025Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3978025PubMed
3899669Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3899669PubMed
3803413Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3803413PubMed
3076134Pinacidil. Preclinical investigations.Drugs1988https://conductscience.org/library/papers/3076134PubMed
2855517In vitro studies on the mode of action of pinacidil.Drugs1988https://conductscience.org/library/papers/2855517PubMed
2848206The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/2848206PubMed
2674897Smooth muscle K+ channel openers; their pharmacology and clinical potential.Pflugers Arch1989https://conductscience.org/library/papers/2674897PubMed
2488102Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2488102PubMed
2196168Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.Drugs1990https://conductscience.org/library/papers/2196168PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/691003

GET https://conductscience.org/api/papers/v1/691003/cited_by?page=2